MediPharm Labs expands production capacity by 50 per cent
MediPharm Labs expands production capacity by 50 per cent
Perth, Dec 27, 2018 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release announcing that MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) has expandedits annual production capacity by 50 per cent.

MMJ owns approximately 4.4 million shares for a 4.5% shareholding and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

To view the release, please visit:

About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit:



Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819

Related Companies

MMJ Group Holdings Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 63) (Last 30 Days: 225) (Since Published: 2686) 

MMJ Group Holdings Ltd NEWS: RECENT VISITS (49292)

Research Report

Social Media